Arena Pharma (ARNA) BELVIQ Trends Remain Underwhelming, BMO Capital Notes

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. SPY
9. IVBIY
10. FIX

Go back to Arena Pharma (ARNA) BELVIQ Trends Remain Underwhelming, BMO Capital Notes

Arena Pharma (ARNA), Eisai Will Present Lorcaserin HCl Data at Two Upcoming Meetings

May 14, 2015 8:02 AM EDT

Eisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced that lorcaserin HCl data will be presented at the following medical meetings:

American Thoracic Society International Conference taking place in Denver, Colorado, May 15-20, 2015Lorcaserin for Smoking Cessation Treatment in Cigarette Smokers:... More

Arena Pharma (ARNA) Tops Q1 EPS by 4c

May 11, 2015 4:09 PM EDT

Arena Pharma (NASDAQ: ARNA) reported Q1 EPS of ($0.10), $0.04 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $12.3 million versus the consensus estimate of $10.56 million.

At March 31, 2015, cash and cash equivalents totaled $241.0 million, including net proceeds of $100.7 million from... More